Tech Company Financing Transactions
TheraVasc Funding Round
TheraVasc, based in Cleveland, secured $172.5 thousand in investment from private investors.
Transaction Overview
Company Name
Announced On
11/18/2013
Transaction Type
Venture Equity
Amount
$172,501
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10000 Cedar Ave. GCIC2 - 102
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Overview
TheraVasc, Inc. is a privately-held biotechnology company with offices in Louisiana, focused on the development of novel vascular therapies with decreased risks through the repositioning of drugs with known safety profiles. The Company's first program is ready to enter clinical trials for the treatment of peripheral artery disease (PAD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tony Giordano
Chief Medical Officer
Amol Soin
Chief Scientific Officer
Chris Kevil
Browse more venture capital transactions:
Prev: 11/18/2013: Lumense venture capital transaction
Next: 11/18/2013: Trivascular Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs